Evaluate Safety, Tolerability, Pharmacokinetics and Immunogenicity of MEDI7352 in Healthy Volunteers

Trial Identifier: D5680C00004
Sponsor: AstraZeneca
NCTID:: NCT04770428
Start Date: April 2021
Primary Completion Date: December 2021
Study Completion Date: December 2021

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
Japanese Translation

Trial Locations

Country Location
GB Harrow, GB, HA1 3UJ